Evogenes Fourth Quarter with Full Year 2015 Earnings Announcement Schedule09/02/2016
Rehovot, Israel – February 9th, 2016– Evogene Ltd. (NYSE, TASE: EVGN), a leading company for the improvement of crop productivity and economics for the food, feed and biofuel industries, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2015 on Tuesday, March 1st, 2016.
On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call, please dial 1-888-668-9141 toll free from the United States, or 972-3-918-0609 internationally. Access to the call will also be available via live webcast through the Company’s website at www.evogene.com.
A replay of the conference call will be available approximately three hours following the completion of the call. To access the replay, please dial 1-888-326-9310 toll free from the United States, or 972-3-925-5900 internationally. The replay will be accessible through March 3rd, 2016, and an archive of the webcast will be available on the Company’s website through March 11th, 2016.
About Evogene Ltd.:
Evogene (NYSE, TASE: EVGN) is a leading company for the improvement of crop productivity and economics for the food and feed industries. The Company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease and nematodes), in key crops as corn, soybean, wheat and rice, and is also focused on the research and development of new products for crop protection (such as weed control). In addition, the Company has a wholly-owned subsidiary, Evofuel, developing seeds for feedstock for biodiesel. For more information, please visit www.evogene.com.
This press release contains "forward-looking statements" relating to future events. These statements may be identified by words such as "may", “expects”, "intends", “anticipates”, “plans”, “believes”, “scheduled”, “estimates” or words of similar meaning. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties which are difficult to predict and are not guarantees of future performance. Therefore, actual future results, performance or achievements of Evogene may differ materially from what is expressed or implied by such forward-looking statements due to a variety of factors, many of which beyond Evogene's control, including, without limitation, those risk factors contained in Evogene’s reports filed with the appropriate securities authority. Evogene disclaims any obligation or commitment to update these forward-looking statements to reflect future events or developments or changes in expectations, estimates, projections and assumptions.
Press releases for 2016
- Evogene to Present Innovative Approach for Improving Cannabis for Medical Needs at CannaTech Summit
- Evogene Reports Fourth Quarter and Full Year 2016 Financial Results
- Evogene and ICL Innovation Sign Collaboration for Development of Crop Enhancers
- Evogene Fourth Quarter and Full Year 2016 Earnings Announcement Schedule
- Evogene to Transfer Stock Exchange Listing to Nasdaq
- Evogene Reports Third Quarter 2016 Financial Results
- Evogene Announces Positive Field Trial Results in Ag-biologicals Program
- Evogene Third Quarter 2016 Earnings Announcement Schedule
- Evogene and IMAmt Sign Collaboration for Genomic Promoter Discovery and Validation in Cotton
- Evogene Announces Joint Microbial Diversity Activity with University of Missouri
- Evogene Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
- Evogene Appoints a New Member to Board of Directors and a New Chief Operating Officer
- Evogene Reports Second Quarter 2016 Financial Results
- Evogene to Participate at Piper Jaffray Global Agriculture Symposium
- Evogene Second Quarter 2016 Earnings Announcement Schedule
- Evogene to Present at Crops and Chemicals 2016 Conference
- Evogene Reports Financial Results for the First Quarter of 2016
- Evogene and Marrone Bio Innovations Disclose Positive Results in Insect Control Collaboration
- Evogene to Present the Potential of Integrating Novel Genome Editing Technology with its Core Capabilities for Improved Seed Traits at Plant Genomics Congress
- Evogene’s First Quarter 2016 Earnings Announcement Schedule
- Evogene Files Annual Report for the Year Ended December 31, 2015
- Evogene Selected for Photosynthesis Research Consortium within European Horizon 2020 Program
- Evogene Reports Fourth Quarter and Full Year 2015 Financial Results
- Evogene Discloses Positive Results in Yield Improvement Collaboration with Monsanto Utilizing Novel 'Trait-First' Methodology
- Evogenes Fourth Quarter with Full Year 2015 Earnings Announcement Schedule